ESGO 2018: New insights in Rare Gynaecological Malignancies is organized by European Society of Gynaecological Oncology (ESGO) and will be held from Oct 04 - 06, 2018 at Palace of the Bourse, Lyon, Lyon, Auvergne-Rhone-Alpes, France. This CME Conference has been approved for a maximum of 14 European CME credits.
The programme of 2018 conference will focus on providing the evidence base to diagnose and manage rare gynecological cancers. The multidisciplinary conference will provide comprehensive state-of-the-art summaries from keynote speakers on specific rare cancers, up to date scientific reviews on biology, biomarkers, preservation of fertility, updated GCIG/ESGO guidelines, discussion of unanswered questions and the design of future clinical trials.
These are topics of great interest for gynecological surgeons, medical and radiation oncologists, pathologists and general gynecologists. Together with the distinguished faculty, we anticipate 400-500 delegates will attend this conference.
Unfortunately, little attention has been paid to the topic of rare cancers by physicians, medical societies, and governments for many years. By attending ESGO’s educational events you could contribute to improvements in the management of gynecological malignancies and identification of innovative therapies which remains a social responsibility of our Society.
Conference Highlights :
• Conference dedicated to "rare" gynecological cancers, which comprise half of cancer in this population
• Focus on providing the evidence base to diagnose and manage rare gynecological cancers including Comprehensive state-of-the-art summaries from keynote speakers on specific rare cancers
• Up to date scientific reviews on biology, biomarkers, preservation of fertility, updated GCIG/ESGO guidelines
• Discussion of unanswered questions, design of future clinical trials, organization (national & international) for management of rare situations
Additional details will be posted as soon as they are available.